Cikarang, August 16, 2024 – To support the Government's Efforts to Improve Medical Education in Indonesia, Prodia Group, a prominent healthcare company in Indonesia established a strategic collaboration with the Faculty of Medicine at President University. This partnership involves several Prodia Group business units in the medical device industry, including PT Prodia Diagnostic Line (Proline) and PT Innovasi Diagnostika (Innodia). The collaboration was inaugurated by Andi Wijaya, Founder and Chairman of Prodia Group, and Handa S. Abidin, Rector of President University, accompanied by Cristina Sandjaja, Director of PT Prodia Diagnostic Line, and Budi Setiabudiawan, Dean of the Faculty of Medicine at President University. The event was also attended by several directors from Prodia Group companies and other invited guests.

Andi Wijaya, Founder and Chairman of Prodia Group, stated, "This strategic collaboration is expected to be the first step and a tangible contribution of Prodia Group in improving the quality of healthcare for the Indonesian people. One way to do this is by fostering collaboration between industry players and educational institutions like President University. With the advantages of Prodia Group as a pioneer in the healthcare industry, ensuring safety, quality, and efficacy, we hope to support relevant, beneficial, and high-quality innovations for Indonesia's education and healthcare sectors."

Through this strategic collaboration, Prodia Group, via its subsidiaries, is conducting a series of programs to support the study process for medical students at President University. These programs include donations of laboratory equipment such as the DYMIND DH33 Auto & Semi-automatic Photometer series PROLINE DPC16 from Proline, the provision of Centrifuges and Microscopes from Innodia, and programs introducing diagnostic laboratory equipment to the academic community at President University by Proline and Innodia. The collaboration will be expanded to include other Prodia Group companies such as Prodia Stemcell (ProSTEM), Prodia CRO, and Prodia OHI.